Sanofi picked up Blueprint Medicines in a deal worth up to $9.5 billion. Bristol Myers Squibb will pay $1.5 billion upfront ...

Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

After 16 years at the helm of one of Richmond's premier high school football programs, former University of Richmond star ...

In this video interview, Jim Kremidas, executive director, Association for MultiSite Research Corporations (AMRC), discusses ...

Here are some highlights from the first half of the year: ...

Billions of dollars worth of U.S. biomanufacturing plant development has been announced, and site selection will likely be ...

Tech funds enjoyed a strong recovery while bonds suffered, according to FE fundinfo fund performance data for May. US trade ...

So far, China has made no official public threat about weaponizing its dominant position in this segment of the ...

How a bold pitch on a black bear hunt turned into a lasting alliance—and a ticket to the inner circle of Trump's Washington.

President Trump’s America First policies have fueled trillions in U.S. investments, creating jobs and boosting domestic ...

The risk of recurrence or death after surgery for deficient mismatch repair (dMMR) colon cancer decreased by 50% in patients ...

Ratcheting up the tariff rhetoric has consistently sent the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average into ...